Showing results (521-530 of 556) with videos related to
Sort By:
Pageof 56
Bulletin of Entomological Research|July 12, 2017
Loss of cane and sugar yield resulting from Ceratovacuna lanigera Zehntner damage in cane-growing regions in ChinaW F Li, R Y Zhang, Y K Huang, et al.Analytical Chemistry|May 17, 2001
Quantitative analysis of bacterial and mammalian proteomes using a combination of cysteine affinity tags and 15N-metabolic labelingT P Conrads, K Alving, T D Veenstra, et al.[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|August 28, 2020
[Prevalence and risk factors of pterygium in Han and Yugur populations in Gansu Province, China]Z X Pan, G L Shan, X J Wang, et al.Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|September 2, 2019
[The mediating role of psychological resilience to childhood abuse and binge eating among middle school students]Y Zhang, H F Wang, Y S Ning, et al.Archives of Virology|September 23, 2006
Real-time quantitative assay of HCV RNA using the duplex scorpion primerS-X Xu, K Lan, Y-L Shan, et al.The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterizationD L Donnelly-Roberts, P S Puttfarcken, T A Kuntzweiler, et al.Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonistN H Lin, D E Gunn, Y Li, et al.Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|May 13, 2020
[Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features]Y X Xiao, X L Zhu, R Bi, et al.International Journal of Andrology|April 9, 2010
Association of androgen receptor CAG repeat polymorphism with VO₂max response to hypoxic training in North China Han menH Y Wang, Y Hu, S H Wang, et al.Breast Cancer Research and Treatment|August 31, 2000
Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinomaQ F Yang, T Sakurai, G Yoshimura, et al.Pageof 56